Cargando…
Nano to micro delivery systems: targeting angiogenesis in brain tumors
Treating brain tumors using inhibitors of angiogenesis is extensively researched and tested in clinical trials. Although anti-angiogenic treatment holds a great potential for treating primary and secondary brain tumors, no clinical treatment is currently approved for brain tumor patients. One of the...
Autores principales: | , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2964525/ https://www.ncbi.nlm.nih.gov/pubmed/20932320 http://dx.doi.org/10.1186/2040-2384-2-20 |